Pharmacology of Parkinson's Disease plus CPC w/Patient Flashcards

1
Q

What is the difference between L-DOPA and carbidopa?

A

L-DOPA is the precursor to dopamine.

Carbidopa inhibits DOPA decarboxylase in the peripheral tissues (it doesn’t get into the CNS), and thus ensures that L-DOPA doesn’t cause PNS stimulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Comtan (entacapone) treats Parkinson’s by ___________.

A

inhibiting COMT (catecholamine-O-methyl transferase), thereby preventing the degradation of dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Parkinson the doctor called his disorder ___________.

A

shaking palsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are Lewy bodies?

A

Protein precipitates that resemble nuclei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

People develop Parkinson’s when they’ve lost _______ percent of their substantia nigra cells.

A

50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

“The cortex initiates movement, but the subcortical nuclei are necessary for _____________.”

A

modulating that movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What percent of people over age 60 have Parkinson’s?

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What environmental factors have been shown to increase or decrease the likelihood of developing Parkinson’s?

A

Increase: well water; pesticides; copper; iron

Decrease: tea; coffee; smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Loss of the dopamine-producing neurons of the substantia nigra lead to a deficit of dopamine in the ______________.

A

caudate and putamen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The enzyme _________ makes dopamine from L-DOPA.

A

DDC (DOPA decarboxylase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does carbidopa work?

A

It inhibits the peripheral enzyme decarboxylase, which converts L-DOPA to dopamine, so that L-DOPA gets into the CNS. Decarboxylase is not in the CNS and thus a higher percent of the L-DOPA given makes it to the brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Amantadine facilitates the _____________.

A

release of endogenous dopamine (also uncertain role as glutamate antagonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why do you need to give anticholinergics to those with Parkinson’s?

A

Because dopamine inhibits cholinergic neurons in the CNS. Thus, in its absence, cholinergic neurons fire faster and overstimulate the CNS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

By what end result does dopamine let us move?

A

It induces the striatum (directly) and globus pallidus (indirectly) to reduce their GABA secretion, thus inhibiting movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The average age of onset of Parkinson’s is _______.

A

60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the short- and long-term complications of L-DOPA?

A

Short: nausea, depression, psychosis, and hypotension
Long: dyskinesia

17
Q

What is the primary purpose of dopamine agonists (such as apomorphine, pramipexole, and ropinirole)?

A

To blunt the on-off effect of L-DOPA

18
Q

The annual cost of having Parkinson’s is roughly ________.

A

$24,000

19
Q

What areas are stimulated by DPS to alleviate the symptoms of Parkinson’s?

A

Thalamus
Internal pallidum
Subthalamic nucleus

20
Q

Some __________ trials have shown that patients no longer need L-DOPA.

A

fetal dopamine cell transplant